Related Experiment Videos
Calcium-channel blockers for prophylaxis of radiocontrast-associated nephrotoxicity
1Department of Pharmacy Practice and Administration, College of Pharmacy, Rutgers, State University of New Jersey, Piscataway 08855, USA.
The Annals of Pharmacotherapy
|February 1, 1995
Abstract:
Because of both an absence of sufficient data and the concern for increased toxicity in certain patient populations, the use of CCBs to reduce radiocontrast-associated nephrotoxicity is not recommended. Additional prospective, randomized trials are needed.